Quoin Pharmaceuticals Employees

As of December 31, 2024, Quoin Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees increased by 1 or 25.00% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

25.00%

Revenue / Employee

n/a

Profits / Employee

-$2,433,855

Market Cap

4.22M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	5	1	25.00%
Dec 31, 2023	4	0	-
Dec 31, 2022	4	0	-
Dec 31, 2021	4	2	100.00%
Dec 31, 2020	2	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

QNRX News

2 days ago - Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton - GlobeNewsWire
16 days ago - Quoin Pharmaceuticals Provides Product Portfolio Update - GlobeNewsWire
3 months ago - Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome - GlobeNewsWire
3 months ago - Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study - GlobeNewsWire
3 months ago - Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule - GlobeNewsWire
4 months ago - Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign - GlobeNewsWire
4 months ago - Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient - GlobeNewsWire
4 months ago - Sphere Bio launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for efficient single-cell selection - Business Wire

More News